Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mary Ann Cox
A Selective and Potent CXCR3 Antagonist SCH 546738 Attenuates the Development of Autoimmune Diseases and Delays Graft Rejection
BMC Immunology
Immunology
Related publications
Dihydroartemisinin Attenuates Autoimmune Thyroiditis by Inhibiting the CXCR3/PI3K/AKT/NF-κB Signaling Pathway
Oncotarget
Oncology
FPL 66096: A Novel, Highly Potent and Selective Antagonist at Human Platelet P2t-Purinoceptors
British Journal of Pharmacology
Pharmacology
The Experimental Treatment of Corneal Graft Rejection With the Interleukin-1 Receptor Antagonist (IL-1ra) Gene
PLoS ONE
Multidisciplinary
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8
Design and Development of a Series of Potent and Selective Type II Inhibitors of CDK8
Z944, a Novel Selective T-Type Calcium Channel Antagonist Delays the Progression of Seizures in the Amygdala Kindling Model
PLoS ONE
Multidisciplinary
Development of Highly Potent and Selective Diaminothiazole Inhibitors of Cyclin-Dependent Kinases
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Vitiligo and Autoimmune Diseases
Przeglad Dermatologiczny
Dermatology
Antiemetic Effect of a Potent and Selective Neurokinin-1 Receptor Antagonist, FK886, on Cisplatin-Induced Acute and Delayed Emesis in Ferrets
Biological and Pharmaceutical Bulletin
Medicine
Pharmacology
Pharmaceutical Science